Membrane Protective Technologies, Inc. (MPTI), founded in Fort Collins, US, is dedicated to enhancing the effectiveness of artificial insemination through innovative sperm protection technologies. Their core mission is to improve fertility outcomes by safeguarding sperm health. MPTI offers a suite of patented products, including GameteGuard™, an organic semen extender-additive that protects sperm cell membranes from damage caused by cooling, freezing, and thawing processes, thereby increasing pregnancy rates.

Notable figures associated with MPTI include experts in reproductive science and technology. The company has attracted significant attention from investors interested in advancing agricultural and veterinary reproductive technologies. Key achievements include the successful development and patenting of their flagship product, GameteGuard™, which has shown to significantly improve sperm viability and fertility rates. MPTI's impact is evident in its contribution to higher success rates in artificial insemination, benefiting both the agricultural industry and veterinary practices.